Home » Topics » BioWorld Science, Dermatologic

BioWorld Science, Dermatologic
RSS

Krystal Biotech receives equity-based award to support epidermolysis bullosa work

Nov. 7, 2017

Enrollment begins in phase I study of Samumed's SM-04755

Nov. 3, 2017

NeoMatrix Therapeutics to begin clinical testing of NMT-cP12

Nov. 3, 2017

Risankizumab meets all co-primary endpoints in pivotal phase III psoriasis studies

Oct. 27, 2017

Brickell Biotech reports results of confirmatory phase IIb study of sofpironium bromide

Oct. 25, 2017

Corbus Pharmaceuticals reports positive results from phase II study of anabasum in dermatomyositis

Oct. 20, 2017

AOBiome reports positive results from phase IIb study of AOB candidate for acne

Oct. 20, 2017

Biosimilar GP-2017 shows efficacy similar to adalimumab in psoriasis patients

Oct. 18, 2017

FDA approves Stelara for adolescents with moderate to severe plaque psoriasis

Oct. 16, 2017

Melinta Therapeutics completes phase I study of radezolid in acne

Oct. 11, 2017

Popular Stories

Today's news in brief
BioWorld
Precision psychiatry beyond, or before, biomarkers
BioWorld
There is broad agreement that psychiatric diagnoses in their current form are not reflective of any underlying biology, and that this is one of the things...
Keros reports beneficial effects of RKER-065 in ALS model
BioWorld Science
Keros Therapeutics Inc. has presented data regarding their activin receptor ligand trap, RKER-065, for the inhibition of the activin/myostatin signaling axis.
News in brief
BioWorld Asia
BioWorld Asia briefs for March 17, 2026
First-in-class POLG activator restores mtDNA across mutations
BioWorld Science
Researchers from Pretzel Therapeutics Inc. presented preclinical data of PX-578, a first-in-class POLG activator aimed at restoring mtDNA replication and...